Where it comes from
- Made in
- The same neurons as neuropeptide FF
- Sent out by
- With neuropeptide FF
- Acts on
- Opioid and cardiovascular circuits
What it does
- Modulates opioids like neuropeptide FF, with which it was isolated from the same brain extract 1
- Prefers NPFFR2, as neuropeptide FF does, so nothing in its pharmacology separates the two 2
- Little studied on its own: almost every experiment in the field uses the shorter peptide as the family’s representative 3
In medicine
- No medicine copies it or blocks it, and it is not measured in people
- Nothing in the clinic would distinguish it from neuropeptide FF: an NPFF receptor blocker blocks both at once 2
Beyond the body’s own use
- Nothing containing it is in trials, approved or obtainable outside the laboratory
- Its difference from neuropeptide FF is length rather than action: eighteen residues against eight, both ending in Arg-Phe-amide, and the extra ten slow its clearance without changing which receptors it uses 2
- What is unknown is whether the body ever needs the long form. One precursor makes both, no tissue is known to make one alone, and no animal has been made that can produce neuropeptide FF without neuropeptide AF 1
Sources
- Yang et al., Two brain neuropeptides that modulate the action of morphine, PNAS 1985
- Bonini et al., Identification and characterization of two G protein-coupled receptors for neuropeptide FF, Journal of Biological Chemistry 2000
- Elhabazi et al., Endogenous RF-amide peptides modulate nociception and morphine analgesia via NPFF receptors, Neuropharmacology 2013
This card describes what a medicine is for and what the evidence says; it recommends nothing. Talk to your clinician about anything you read here.